BioCentury | Nov 3, 2008
Clinical News

Opgenra regulatory update

...BioCentury, June 30). The recombinant human osteogenic protein-1/eptotermin already is approved to repair tibia fractures. Stryker Biotech...
BioCentury | Jun 30, 2008
Clinical News

Opgenra regulatory update

...autograft has failed. The recombinant human osteogenic protein-1/eptotermin is already approved to repair tibia fractures. Stryker Biotech...
BioCentury | Nov 22, 2004
Company News

Anika management update

...Business: Dermatology Hired: Carol Ann Toth as VP of R&D, formerly VP of R&D at Stryker Biotech...
BioCentury | Aug 23, 2004
Company News

Integrated Pharmaceuticals management update

...Infectious Hired: Hermann Oppermann as VP of biologics development, formerly director of molecular biology at Stryker Biotech...
Items per page:
1 - 4 of 4
BioCentury | Nov 3, 2008
Clinical News

Opgenra regulatory update

...BioCentury, June 30). The recombinant human osteogenic protein-1/eptotermin already is approved to repair tibia fractures. Stryker Biotech...
BioCentury | Jun 30, 2008
Clinical News

Opgenra regulatory update

...autograft has failed. The recombinant human osteogenic protein-1/eptotermin is already approved to repair tibia fractures. Stryker Biotech...
BioCentury | Nov 22, 2004
Company News

Anika management update

...Business: Dermatology Hired: Carol Ann Toth as VP of R&D, formerly VP of R&D at Stryker Biotech...
BioCentury | Aug 23, 2004
Company News

Integrated Pharmaceuticals management update

...Infectious Hired: Hermann Oppermann as VP of biologics development, formerly director of molecular biology at Stryker Biotech...
Items per page:
1 - 4 of 4